XML 48 R21.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Goodwill and Intangible Assets, Net
 12 Months Ended
Dec. 29, 2019
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Intangible Assets, Net
Goodwill and Intangible Assets, Net
 
The Company tests goodwill and non-amortizing intangible assets at least annually for possible impairment. Accordingly, the Company completes the annual testing of impairment for goodwill and non-amortizing intangible assets on the later of January 1 or the first day of each fiscal year. In addition to its annual test, the Company regularly evaluates whether events or circumstances have occurred that may indicate a potential impairment of goodwill or non-amortizing intangible assets.
The process of testing goodwill for impairment involves the determination of the fair value of the applicable reporting units. The test consists of the comparison of the fair value to the carrying value of the reporting unit to determine if the carrying value exceeds the fair value. If the carrying value of the reporting unit exceeds its fair value, an impairment loss in an amount equal to that excess is recognized up to the amount of goodwill. The Company performed its annual impairment testing for its reporting units as of January 1, 2019, its annual impairment testing date for fiscal year 2019.
Non-amortizing intangibles are also subject to an annual impairment test. The Company consistently employed the relief from royalty model to estimate the current fair value when testing for impairment of non-amortizing intangible asset. The impairment test consists of a comparison of the fair value of the non-amortizing intangible asset with its carrying amount. If the carrying amount of a non-amortizing intangible asset exceeds its fair value, an impairment loss in an amount equal to that excess is recognized up to the amount of the amortizing intangible asset. In addition, the Company evaluates the remaining useful life of our non-amortizing intangible asset at least annually to determine whether events or circumstances continue to support an indefinite useful life. If events or circumstances indicate that the useful life of our non-amortizing intangible asset is no longer indefinite, the asset will be tested for impairment. This intangible asset will then be amortized prospectively over its estimated remaining useful life and accounted for in the same manner as other intangible assets that are subject to amortization.
    The changes in the carrying amount of goodwill for fiscal years 2019 and 2018 are as follows:
 
 
 
Discovery & Analytical Solutions

 
Diagnostics
 
Consolidated
 
 
Balance at December 31, 2017
 
$
1,344,235

 
$
1,657,963

 
$
3,002,198

Foreign currency translation
 
(32,189
)
 
(35,289
)
 
(67,478
)
Acquisitions, earnouts and other
 
22,946

 
(5,058
)
 
17,888

Balance at December 30, 2018
 
1,334,992

 
1,617,616

 
2,952,608

Foreign currency translation
 
(8,559
)
 
(9,725
)
 
(18,284
)
Acquisitions, earnouts and other
 
172,387

 
4,516

 
176,903

Balance at December 29, 2019
 
$
1,498,820

 
$
1,612,407

 
$
3,111,227


 
Identifiable intangible asset balances at December 29, 2019 by category and by business segment were as follows:
 
 
Discovery & Analytical Solutions

 
Diagnostics
 
Consolidated
 
 
Patents
$
28,122

 
$
2,709

 
$
30,831

Less: Accumulated amortization
(27,142
)
 
(281
)
 
(27,423
)
Net patents
980

 
2,428

 
3,408

Trade names and trademarks
39,859

 
48,138

 
87,997

Less: Accumulated amortization
(23,632
)
 
(16,663
)
 
(40,295
)
Net trade names and trademarks
16,227

 
31,475

 
47,702

Licenses
50,393

 
8,103

 
58,496

Less: Accumulated amortization
(47,607
)
 
(2,126
)
 
(49,733
)
Net licenses
2,786

 
5,977

 
8,763

Core technology
390,116

 
298,973

 
689,089

Less: Accumulated amortization
(205,263
)
 
(115,663
)
 
(320,926
)
Net core technology
184,853

 
183,310

 
368,163

Customer relationships
313,898

 
847,628

 
1,161,526

Less: Accumulated amortization
(156,967
)
 
(221,221
)
 
(378,188
)
Net customer relationships
156,931

 
626,407

 
783,338

IPR&D
—

 
1,328

 
1,328

Net amortizable intangible assets
361,777

 
850,925

 
1,212,702

Non-amortizing intangible asset:
 
 
 
 
 
Trade name
70,584

 
—

 
70,584

Total
$
432,361

 
$
850,925

 
$
1,283,286


Identifiable intangible asset balances at December 30, 2018 by category and business segment were as follows:
 
 
Discovery & Analytical Solutions

 
Diagnostics
 
Consolidated
 
 
Patents
$
28,030

 
$
14,616

 
$
42,646

Less: Accumulated amortization
(25,978
)
 
(11,775
)
 
(37,753
)
Net patents
2,052

 
2,841

 
4,893

Trade names and trademarks
29,811

 
48,335

 
78,146

Less: Accumulated amortization
(21,728
)
 
(12,073
)
 
(33,801
)
Net trade names and trademarks
8,083

 
36,262

 
44,345

Licenses
50,178

 
3,127

 
53,305

Less: Accumulated amortization
(44,376
)
 
(1,174
)
 
(45,550
)
Net licenses
5,802

 
1,953

 
7,755

Core technology
240,734

 
300,177

 
540,911

Less: Accumulated amortization
(189,033
)
 
(76,711
)
 
(265,744
)
Net core technology
51,701

 
223,466

 
275,167

Customer relationships
222,892

 
866,635

 
1,089,527

Less: Accumulated amortization
(128,142
)
 
(165,822
)
 
(293,964
)
Net customer relationships
94,750

 
700,813

 
795,563

IPR&D
—

 
1,360

 
1,360

Net amortizable intangible assets
162,388

 
966,695

 
1,129,083

Non-amortizing intangible asset:
 
 
 
 
 
Trade name
70,584

 
—

 
70,584

Total
$
232,972

 
$
966,695

 
$
1,199,667


 
Total amortization expense related to definite-lived intangible assets was $164.3 million in fiscal year 2019, $135.9 million in fiscal year 2018 and $73.7 million in fiscal year 2017. Estimated amortization expense related to definite-lived intangible assets for each of the next five years is $188.8 million in fiscal year 2020, $173.0 million in fiscal year 2021, $156.6 million in fiscal year 2022, $132.6 million in fiscal year 2023, and $111.3 million in fiscal year 2024.